Fig. 1From: Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndromeLevels of betatrophin in various metabolic abnormalities. Betatrophin concentrations were compared between subjects with and without a central obesity, b elevated blood pressures, c high TG, d low HDL-C and g NAFLD, and subjects with different e glucose tolerance status (normal, IGT/IFG, or T2DM, f number of MS components (0, 1, 2, or ≥ 3) and h vitamin D tertile ( T1, 3.00–11.94 ng/ml; T2, 11.94–17.04 ng/ml; and T3, 17.04–35.61 ng/ml). Data are natural log-transformed and shown as mean ± SEM. All P values were adjusted for gender and age and P* was further adjusted for vitamin D levels. NS no significant difference; TG triglycerides; HDL-C high-density lipoprotein cholesterol; MS metabolic syndrome; IFG impaired fasting glucose; IGT impaired glucose tolerance; T2DM type 2 diabetes mellitus; NAFLD nonalcoholic fatty liver diseaseBack to article page